본문 바로가기
  • Home
Basic Search

Patient End-of-life Decision Act and Bio-power -forgoing life-sustaining treatment from perspective of Foucault’s bio-power-

  • PHILOSOPHY·THOUGHT·CULTURE
  • 2022, (38), pp.177~197
  • DOI : 10.33639/ptc.2022..38.008
  • Publisher : Research Institute for East-West Thought
  • Research Area : Humanities > Other Humanities
  • Received : December 30, 2021
  • Accepted : January 31, 2022
  • Published : January 31, 2022

KIM DO KYONG ORD ID 1

1동아대학교

Accredited

ABSTRACT

As end-of-life care was carried out in hospital and life extension technology developed, judicial judgement has become intervened in decision making at the end of life. After the Boramae hospital case, medical culture has been formed to avoid discontinuation of treatment. And now the decision making of life-sustaining treatment is being made in accordance with Patient end-of-life decision act. Although the act aims to practice the patient’s right to self-determination and best interests, the institutionalized procedure for forgoing life-sustaining treatment functions as a technology of bio-power to mange the population in imminent death rather than death as a individual’s self-fulfillment. The perspective of Foucault’s bio-power by analysing the act reveal the normalization of forgoing life-sustaining treatment and the act as security mechanism in period of end-of-life.

Statistics

  • 246 Viewed
  • 168 Downloaded

Tools

Issue List

Citation status

* References for papers published after 2023 are currently being built.

This paper was written with support from the National Research Foundation of Korea.
Basic Search Advanced Search